2023

Daratumumab as a novel treatment option in refractory ITP.
Vernava, I. and Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226
Blood Cells Molecules and Diseases 99 : 102724. March 2023

2005

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
Holdhoff, M., Kreuzer, K.A., Appelt, C., Scholz, R., Na, I.K. ORCID: https://orcid.org/0000-0001-9902-5424, Hildebrandt, B., Riess, H., Jordan, A., Schmidt, C.A., Van Etten, R.A., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643 and LeCoutre, P.
Blood Cells Molecules and Diseases 34 (2): 181-185. 1 March 2005

2002

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.
le Coutre, P., Kreuzer, K.A., Na, I.K. ORCID: https://orcid.org/0000-0001-9902-5424, Lupberger, J., Holdhoff, M., Appelt, C., Schwarz, M., Mueller, C., Gambacorti-Passerini, C., Platzbecker, U., Bonnet, R., Ehninger, G. and Schmidt, C.A.
Blood Cells Molecules and Diseases 28 (1): 75-85. January 2002

2001

Bcl-2 mediates chemoresistance in matched pairs of primary Emu-myc lymphomas in vivo.
Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226 and Lowe, S.W.
Blood Cells Molecules and Diseases 27 (1): 206-216. January 2001